Learn about Cannabis and Polypharmacy with your free report!
This custom study was undertaken by Strainprint to understand polypharmacy behavior and attitudes among 1,016 Strainprint app users, all of whom are medical cannabis patients. Data was collected from February 7, 2019, to February 19, 2019.
Methodology: 10-15 minute online custom survey
Sample Size: 1,016
Efficacy Calc: XY
Statistics Used: Chi Square, Spearman R correlations
- Patients are mixing molecular drugs with cannabis as a form of therapy even though the combined effects have not been fully studied.
- Cannabis has potential as an adjunct therapy and 40% of patients are seeing the use of cannabis alongside molecular drugs as the most effective therapy.
- The overall polypharmacy behavior across age ranges was very similar, but there are significant differences in the conditions in which each age group is treating.